{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T15:25:27Z","timestamp":1725031527704},"reference-count":23,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1136\/bjophthalmol-2014-305506","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T09:18:30Z","timestamp":1408526310000},"page":"251-254","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Severity of acute ocular involvement is independently associated with time to resolution of ocular disease in toxic epidermal necrolysis patients"],"prefix":"10.1136","volume":"99","author":[{"given":"Jacob S","family":"Heng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabeel","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naresh","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Claire","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela P","family":"Vizcaychipi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,8,19]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2014-305506-1","doi-asserted-by":"crossref","first-page":"173.e1","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-3","doi-asserted-by":"crossref","first-page":"187.e1","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ajo.2010.04.026","article-title":"Ophthalmic manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis and relation to SCORTEN","volume":"150","author":"Morales","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-5","first-page":"157","article-title":"Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"145","author":"Gueudry","year":"2009","journal-title":"Arch Dermatol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","article-title":"Ocular manifestations and complications of stevens-johnson syndrome and toxic epidermal necrolysis: An asian series","volume":"62","author":"Yip","year":"2007","journal-title":"Allergy"},{"key":"key-10.1136\/bjophthalmol-2014-305506-7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00417-014-2568-8","article-title":"Comprehensive approach to ocular consequences of Stevens Johnson syndrome\u2014the aftermath of a systemic condition","volume":"252","author":"Iyer","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-8","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","article-title":"Analysis of the acute ophthalmic manifestations of the erythema multiforme\/Stevens-Johnson syndrome\/toxic epidermal necrolysis disease spectrum","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-305506-9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: A severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","article-title":"Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: Acute ocular manifestations, causes, and management","volume":"26","author":"Chang","year":"2007","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2014-305506-11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ophtha.2010.06.035","article-title":"Ocular features and histopathologic changes during follow-up of toxic epidermal necrolysis","volume":"118","author":"L\u00f3pez-Garc\u00eda","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-305506-12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.preteyeres.2012.05.003","article-title":"Ocular surface inflammation is regulated by innate immunity","volume":"31","author":"Ueta","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2014-305506-13","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1167\/iovs.13-11859","article-title":"Elevation of conjunctival epithelial cd45intcd11b+CD16+CD14\u2212 neutrophils in ocular Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Williams","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2014-305506-14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ophtha.2013.06.049","article-title":"Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with Stevens-Johnson syndrome and ocular cicatricial pemphigoid","volume":"121","author":"Arafat","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-305506-15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3341\/kjo.2013.27.5.331","article-title":"Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome","volume":"27","author":"Kim","year":"2013","journal-title":"Korean J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3476(89)80736-X","article-title":"Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"115","author":"Prendiville","year":"1989","journal-title":"J Pediatr"},{"key":"key-10.1136\/bjophthalmol-2014-305506-17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0161-6420(90)32479-X","article-title":"Cicatricial pemphigoid and erythema multiforme","volume":"97","author":"Mondino","year":"1990","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-305506-18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archopht.1950.00910010251007","article-title":"Ocular involvement in erythema multiforme","volume":"43","author":"PATZ","year":"1950","journal-title":"Arch Ophthal"},{"key":"key-10.1136\/bjophthalmol-2014-305506-19","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","article-title":"New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome","volume":"114","author":"Sotozono","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-305506-20","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/archdermatol.2009.293","article-title":"The management of severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"145","author":"Sotozono","year":"2009","journal-title":"Arch Dermatol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-21","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1001\/archopht.1987.01060120084031","article-title":"Goblet cell density in thermal and chemical injuries","volume":"105","author":"Ohji","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICU.0b013e3283622718","article-title":"Current ophthalmologic treatment strategies for acute and chronic Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"24","author":"Ciralsky","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-305506-23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/ICO.0b013e318243fee3","article-title":"\u2018Triple-TEN\u2019 in the treatment of acute ocular complications from toxic epidermal necrolysis","volume":"32","author":"Tomlins","year":"2013","journal-title":"Cornea"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2014-305506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:48:20Z","timestamp":1601110100000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2014-305506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,19]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,1,20]]},"published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1136\/bjophthalmol-2014-305506"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305506","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,19]]}}}